Physician profile
Alexander John Schultz
NPI 1780265926
$10,450.22
in general payments reported to CMS, 2019-2025
12 companies · $4,119 in 2025
The $4,119 reported for 2025 was more than what 92% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,297 · 2024: $5,034 · 2025: $4,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,567 · Travel and Lodging: $3,428 · Education: $2,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,567.09 |
| Travel and Lodging | $3,428.20 |
| Education | $2,157.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,701.06 | 2024-2025 | Ortholoc 3di, Inbone, Allofiber |
| Citieffe, INC. | $2,000.00 | 2024 | |
| Mimedx Group, INC. | $1,181.59 | 2025 | |
| Paragon 28, INC. | $925.33 | 2025 | Portfolio, Monkey Rings |
| Abbott Laboratories | $409.57 | 2024-2025 | Esprit, Diamondback Peripheral |
| Treace Medical Concepts, INC. | $249.23 | 2025 | |
| Integra Lifesciences Corporation | $229.87 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $208.91 | 2024-2025 | Stravix, Grafix Pl, Grafix |
| Amgen INC. | $110.02 | 2024 | Krystexxa |
| Polynovo North America LLC | $107.28 | 2024 | Novosorb Btm |
| Alpha Orthopedic Systems | $15.00 | 2024 | |
| Native Surgical, LLC | $14.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.